UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061433
Receipt number R000070292
Scientific Title A retrospective observational study of the natural history and the effects of early diagnosis and treatment of pediatric neurological disorders.
Date of disclosure of the study information 2026/07/01
Last modified on 2026/05/01 14:46:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study of the natural history and the effects of early diagnosis and treatment of pediatric neurological disorders.

Acronym

A retrospective observational study of the natural history and the effects of early diagnosis and treatment of pediatric neurological disorders.

Scientific Title

A retrospective observational study of the natural history and the effects of early diagnosis and treatment of pediatric neurological disorders.

Scientific Title:Acronym

A retrospective observational study of the natural history and the effects of early diagnosis and treatment of pediatric neurological disorders.

Region

Japan


Condition

Condition

Pediatric neurological diseases

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This retrospective study will investigate differences in clinical presentation, treatment response, and long-term prognosis among children diagnosed with pediatric neurological disorders at our hospital, including cases diagnosed after the onset of symptoms and cases diagnosed before symptoms appeared. The aim is to examine factors influencing disease prognosis and contribute to the development of better medical care systems and guidelines for the future.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Assessment of activities of daily living (ADL) (Functional independence assessment scale, pediatric assessment scale)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with pediatric neurological disorders who are receiving treatment at our hospital:
Target diseases: Spinal muscular atrophy, spinocerebellar degeneration, myasthenia gravis, muscular dystrophy, congenital myopathy, epilepsy, tuberous sclerosis, acute encephalitis/encephalopathy, hypoxic-ischemic encephalopathy, neurodevelopmental disorders, mitochondrial diseases, congenital metabolic disorders, hereditary dystonia, chromosomal abnormalities, fragile X syndrome, congenital malformation syndromes, neurodevelopmental disorders, chronic fatigue syndrome, orthostatic dysregulation, Long COVID, etc.

Key exclusion criteria

Not applicable

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Sadao
Middle name
Last name Nakamura

Organization

University of the Ryukyus

Division name

Graduate School of Medicine Department of Developmental Medicine

Zip code

901-2222

Address

1076 Kiyama, Ginowan City, Okinawa Prefecture

TEL

0988941417

Email

h071341@cs.u-ryukyu.ac.jp


Public contact

Name of contact person

1st name Sadao
Middle name
Last name Nakamura

Organization

University of the Ryukyus

Division name

Graduate School of Medicine Department of Developmental Medicine

Zip code

901-2222

Address

1076 Kiyama, Ginowan City, Okinawa Prefecture

TEL

0988941417

Homepage URL


Email

n.sadao39@gmail.com


Sponsor or person

Institute

University of the Ryukyus

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of the Ryukyus

Address

1076 Kiyama, Ginowan City, Okinawa Prefecture

Tel

0988941417

Email

h071341@cs.u-ryukyu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

沖縄県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2030 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This retrospective study will investigate differences in clinical presentation, treatment response, and long-term prognosis among children diagnosed with pediatric neurological disorders residing in Okinawa Prefecture, including cases diagnosed after onset and those diagnosed before symptoms appeared. The study will examine factors influencing disease prognosis and contribute to the development of better medical care systems and guidelines for the future.


Management information

Registered date

2026 Year 05 Month 01 Day

Last modified on

2026 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070292